MEFV and familial Mediterranean fever: Recent evidence has better clarified that FMF is secondary to gain-of-function mutations of MEFV with a dose-dependent effect, so that FMF can be diagnosed in the presence of a consistent clinical phenotype associated with either one or two pathogenic variants (heterozygous in AD disease, homozygous or compound heterozygous in AR disease).